A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study( )

BACKGROUND: Both the elderly and individuals with comorbidities are at increased risk of developing influenza-related complications. Novel influenza antivirals are required, given limitations of current drugs (eg, resistance emergence and poor efficacy). Pimodivir is a first-in-class antiviral for i...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Neil, Brian, Ison, Michael G, Hallouin-Bernard, Marie Charlotte, Nilsson, Anna C, Torres, Antoni, Wilburn, John M, van Duijnhoven, Wilbert, Van Dromme, Ilse, Anderson, David, Deleu, Sofie, Kosoglou, Teddy, Vingerhoets, Johan, Rossenu, Stefaan, Leopold, Lorant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373154/
https://www.ncbi.nlm.nih.gov/pubmed/32604406
http://dx.doi.org/10.1093/infdis/jiaa376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373154/
https://www.ncbi.nlm.nih.gov/pubmed/32604406
http://dx.doi.org/10.1093/infdis/jiaa376

Ejemplares similares